Warning: Sidelined reactor could trigger medical isotope shortage

A critical medical isotope may soon be in short supply, according to reports from suppliers and Nuclear Medicine Europe. 

The impending shortage pertains to molybdenum-99, or Mo-99. A structural issue has occurred with a pipe within the high-flux reactor (HFR) in Petten, Netherlands. An inspection revealed that the pipe will require immediate repair. 

Prior to the inspection, the HFR was set to undergo planned maintenance in December. This repair was planned around the routine maintenance of other HFRs to avoid interfering with the supply of medical isotopes. However, due to the urgent need of the repair, the supply and distribution will inevitably be affected, as the scheduled maintenance of other reactors cannot be changed. 

Mo-99 is critical to the field of nuclear medicine. Its decay product—technetium-99m, or Tc-99m—is used in up to 50,000 medical procedure every day in the United States alone, according to an estimate from the Society of Nuclear Medicine and Molecular Imaging (SNMMI). At a minimum, it could be several weeks before the repair is completed, the American Society of Nuclear Cardiology is reporting. 

This is not the first time the reactor has been unexpectedly sidelined. In early 2022 the Dutch reactor underwent an unplanned outage that disrupted the supply chain of Mo-99 and Lu-177 for months. During that time, other HFRs upped their own production to address the shortage but it is currently unclear whether that will be a possible mitigation tactic this time around. 

Health Imaging will update this story as more details become available. 

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.